首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   71篇
  免费   2篇
  国内免费   3篇
现状及发展   4篇
研究方法   16篇
综合类   54篇
自然研究   2篇
  2022年   1篇
  2019年   1篇
  2018年   1篇
  2017年   2篇
  2016年   2篇
  2014年   1篇
  2013年   2篇
  2012年   8篇
  2011年   8篇
  2010年   2篇
  2009年   1篇
  2008年   9篇
  2007年   5篇
  2006年   6篇
  2005年   7篇
  2004年   6篇
  2003年   4篇
  2002年   8篇
  2000年   2篇
排序方式: 共有76条查询结果,搜索用时 734 毫秒
71.
长线磁致伸缩位移传感器激励波的研究   总被引:3,自引:0,他引:3  
讨论了长线磁致伸缩位移传感器中激励波的产生机理及分布特性,分别对永久磁铁磁场作用下磁致伸缩线材内外磁场和脉冲电流作用下线材内外的周向磁场进行了分析,讨论了在合成磁场作用下弹性波和固支波的相关机理,构建了相应的数据模型。通过建立有限元模型,使用ANSYS仿真平台进行了激励磁场的仿真模拟,获得了激励波的相关参数,为提高该种传感器检测精度提供了理论依据和实验数据。  相似文献   
72.
Kaneda M  Okano M  Hata K  Sado T  Tsujimoto N  Li E  Sasaki H 《Nature》2004,429(6994):900-903
Imprinted genes are epigenetically marked during gametogenesis so that they are exclusively expressed from either the paternal or the maternal allele in offspring. Imprinting prevents parthenogenesis in mammals and is often disrupted in congenital malformation syndromes, tumours and cloned animals. Although de novo DNA methyltransferases of the Dnmt3 family are implicated in maternal imprinting, the lethality of Dnmt3a and Dnmt3b knockout mice has precluded further studies. We here report the disruption of Dnmt3a and Dnmt3b in germ cells, with their preservation in somatic cells, by conditional knockout technology. Offspring from Dnmt3a conditional mutant females die in utero and lack methylation and allele-specific expression at all maternally imprinted loci examined. Dnmt3a conditional mutant males show impaired spermatogenesis and lack methylation at two of three paternally imprinted loci examined in spermatogonia. By contrast, Dnmt3b conditional mutants and their offspring show no apparent phenotype. The phenotype of Dnmt3a conditional mutants is indistinguishable from that of Dnmt3L knockout mice, except for the discrepancy in methylation at one locus. These results indicate that both Dnmt3a and Dnmt3L are required for methylation of most imprinted loci in germ cells, but also suggest the involvement of other factors.  相似文献   
73.
74.
75.
Numerous types of DNA variation exist, ranging from SNPs to larger structural alterations such as copy number variants (CNVs) and inversions. Alignment of DNA sequence from different sources has been used to identify SNPs and intermediate-sized variants (ISVs). However, only a small proportion of total heterogeneity is characterized, and little is known of the characteristics of most smaller-sized (<50 kb) variants. Here we show that genome assembly comparison is a robust approach for identification of all classes of genetic variation. Through comparison of two human assemblies (Celera's R27c compilation and the Build 35 reference sequence), we identified megabases of sequence (in the form of 13,534 putative non-SNP events) that were absent, inverted or polymorphic in one assembly. Database comparison and laboratory experimentation further demonstrated overlap or validation for 240 variable regions and confirmed >1.5 million SNPs. Some differences were simple insertions and deletions, but in regions containing CNVs, segmental duplication and repetitive DNA, they were more complex. Our results uncover substantial undescribed variation in humans, highlighting the need for comprehensive annotation strategies to fully interpret genome scanning and personalized sequencing projects.  相似文献   
76.
Disruption of histone acetylation patterns is a common feature of cancer cells, but very little is known about its genetic basis. We have identified truncating mutations in one of the primary human histone deacetylases, HDAC2, in sporadic carcinomas with microsatellite instability and in tumors arising in individuals with hereditary nonpolyposis colorectal cancer syndrome. The presence of the HDAC2 frameshift mutation causes a loss of HDAC2 protein expression and enzymatic activity and renders these cells more resistant to the usual antiproliferative and proapoptotic effects of histone deacetylase inhibitors. As such drugs may serve as therapeutic agents for cancer, our findings support the use of HDAC2 mutational status in future pharmacogenetic treatment of these individuals.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号